FolioLanternBeta
IMVTImmunovant, Inc.

Jay Stout

Chief Technology Officer at Immunovant, Inc., as of Oct 9, 2026Sold $2.4M of stock in the past 12 months: 35% to cover taxes and 65% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
202K
shares held after the latest filing, Immunovant, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
69K
shares sold, past 12 months
9
days with sales
$1.5M
largest single day, Jun 26, 2026
1
company filed for

Share of stake sold at Immunovant, Inc. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $48K to cover taxesOctNovDecJan 2026: $83K to cover taxesJanFebMarApr 2026: $333K to cover taxesAprMayJun 2026: $1.5M no plan disclosed$1.5MJunJul 2026: $248K to cover taxesJulAugSepOct 2026: $122K to cover taxesOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Immunovant, Inc. (IMVT)Chief Technology OfficerApr 19, 2023Oct 9, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.